CURE51
Description
Cure51 is a pioneering TechBio company, creating the world’s first global database of cancer survivors. In collaboration with leading oncology centers, more than 1,500 survivors have already been identified across 42 countries. With its proprietary data collection and analysis platform, and a central lab dedicated to multi-omic sequencing, Cure51 identifies robust therapeutic targets to develop new curative treatments. The company initially focuses on three aggressive cancer types, with plans to expand to other indications over time.
An event
Held in conjunction with
An organization
